Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model

A Narayanan1, M S Muyyarikkandy2, S Mooyottu2

  • 1Department of Psychology, University of Connecticut, Storrs, CT, USA.

Insights

Trans-cinnamaldehyde (TC), derived from cinnamon, effectively reduced uropathogenic Escherichia coli (UPEC) in mouse lower urinary tract infections. This natural compound shows promise as a non-antibiotic strategy for preventing UTIs.

Area of Science:

  • Microbiology
  • Pharmacology
  • Natural Products

Background:

  • Urinary tract infections (UTIs) cause millions of U.S. hospital visits annually.
  • Uropathogenic Escherichia coli (UPEC) is the primary cause of UTIs.
  • Antibiotic resistance in UPEC necessitates alternative treatments.

Purpose of the Study:

  • To investigate the efficacy of trans-cinnamaldehyde (TC) in combating UPEC.
  • To evaluate TC as a potential prophylactic agent against lower UTIs.

Main Methods:

  • Female mice were fed diets supplemented with varying concentrations of TC (0, 0.1%, 0.2%, 0.4%) for 10 days.
  • Mice were experimentally infected with UPEC via transurethral catheterization.
  • Bacterial counts in the bladder, urethra, and urine were assessed post-infection.

Main Results:

  • Prophylactic TC supplementation significantly reduced UPEC colonization in the bladder and urethra.
  • A dose-dependent reduction in bacterial load was observed with TC treatment.
  • TC demonstrated significant antimicrobial activity against UPEC in a murine UTI model.

Conclusions:

  • Oral TC supplementation is effective in reducing UPEC colonization in lower UTIs.
  • TC presents a viable natural, non-antibiotic alternative for UTI prophylaxis.
  • Further clinical trials are warranted to confirm TC's efficacy in humans.

Related Concept Videos